RHEUMATOID ARTHRITIS AND COVID-19 THE CLINICAL PICTURE DURING THE LIFE OF PATIENTS

Abstract

Since the beginning of the COVID-19 pandemic, a large amount of information has been accumulated concerning not only the clinical picture and outcomes of the disease, but also cases of persistent persistence of various symptoms, such as weakness, low-grade fever, shortness of breath, arthralgia, etc., that arose during or shortly after SARS infection -CoV-2 [1–4]. Thus, Italian authors reported that in 87.4% of patients after hospital treatment for COVID-19, individual symptoms persisted for two months or more [2]. Another study showed that 35 days after hospitalization, convalescents of SARS-CoV-2 infection continued to experience high levels of fatigue, with the majority of study participants reporting decreased quality of life and dissatisfaction with both physical and mental health [4]. Similar results were obtained by other researchers [7].Thus, the interest of clinicians is not limited to information about mortality and outcome of this infection, since it is also necessary to understand the long-term prospects of patients who have recovered from COVID-19.